Acute telogen effluvium associated with SARS-CoV-2 infection
Miguel Domínguez-Santás, Lara Haya‐Martínez, Diego Fernández‐Nieto, Juan Jimenez‐Cauhe, Ana Suárez‐Valle, Borja Díaz‐Guimaraens
Abstract
Acute telogen effluvium has been recognised as a dermatological sequela of COVID-19.
Topics & Concepts
SequelaCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Medicine2019-20 coronavirus outbreakDermatologyVirologyPathologyPsychiatryOutbreakDiseaseInfectious disease (medical specialty)Dermatological and COVID-19 studiesBody Contouring and SurgeryHair Growth and Disorders